vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and enCore Energy Corp. (EU). Click either name above to swap in a different company.

enCore Energy Corp. is the larger business by last-quarter revenue ($12.4M vs $8.1M, roughly 1.5× Arcellx, Inc.). enCore Energy Corp. runs the higher net margin — -173.9% vs -766.0%, a 592.1% gap on every dollar of revenue. enCore Energy Corp. produced more free cash flow last quarter ($7.2M vs $-63.9M).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.

ACLX vs EU — Head-to-Head

Bigger by revenue
EU
EU
1.5× larger
EU
$12.4M
$8.1M
ACLX
Higher net margin
EU
EU
592.1% more per $
EU
-173.9%
-766.0%
ACLX
More free cash flow
EU
EU
$71.1M more FCF
EU
$7.2M
$-63.9M
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
EU
EU
Revenue
$8.1M
$12.4M
Net Profit
$-62.3M
$-21.5M
Gross Margin
37.9%
Operating Margin
-847.6%
-135.9%
Net Margin
-766.0%
-173.9%
Revenue YoY
-79.3%
Net Profit YoY
-765.1%
EPS (diluted)
$-1.13
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
EU
EU
Q4 25
$12.4M
Q3 25
$8.9M
Q2 25
$3.7M
Q1 25
$8.1M
$18.2M
Q4 24
$15.3M
Q3 24
$26.0M
Q2 24
$27.4M
Q1 24
$39.3M
Net Profit
ACLX
ACLX
EU
EU
Q4 25
$-21.5M
Q3 25
$-4.8M
Q2 25
$-6.3M
Q1 25
$-62.3M
$-24.2M
Q4 24
$-47.1M
Q3 24
$-25.9M
Q2 24
$-27.2M
Q1 24
$-7.2M
Gross Margin
ACLX
ACLX
EU
EU
Q4 25
37.9%
Q3 25
43.8%
Q2 25
30.8%
Q1 25
-0.1%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
ACLX
ACLX
EU
EU
Q4 25
-135.9%
Q3 25
-158.2%
Q2 25
-526.1%
Q1 25
-847.6%
-85.7%
Q4 24
-348.2%
Q3 24
-129.1%
Q2 24
-127.8%
Q1 24
-40.3%
Net Margin
ACLX
ACLX
EU
EU
Q4 25
-173.9%
Q3 25
-53.7%
Q2 25
-172.7%
Q1 25
-766.0%
-132.9%
Q4 24
-308.4%
Q3 24
-99.4%
Q2 24
-99.3%
Q1 24
-18.3%
EPS (diluted)
ACLX
ACLX
EU
EU
Q4 25
$-0.11
Q3 25
$-0.03
Q2 25
$-0.03
Q1 25
$-1.13
$-0.13
Q4 24
$-0.87
Q3 24
$-0.48
Q2 24
$-0.51
Q1 24
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
EU
EU
Cash + ST InvestmentsLiquidity on hand
$543.3M
$52.4M
Total DebtLower is stronger
$110.0M
Stockholders' EquityBook value
$416.9M
$229.2M
Total Assets
$648.1M
$430.4M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
EU
EU
Q4 25
$52.4M
Q3 25
$91.9M
Q2 25
$26.9M
Q1 25
$543.3M
$29.7M
Q4 24
$587.4M
Q3 24
$574.3M
Q2 24
$516.7M
Q1 24
$573.9M
Total Debt
ACLX
ACLX
EU
EU
Q4 25
$110.0M
Q3 25
$109.3M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACLX
ACLX
EU
EU
Q4 25
$229.2M
Q3 25
$248.6M
Q2 25
$264.7M
Q1 25
$416.9M
$267.9M
Q4 24
$454.8M
Q3 24
$483.0M
Q2 24
$487.2M
Q1 24
$496.6M
Total Assets
ACLX
ACLX
EU
EU
Q4 25
$430.4M
Q3 25
$441.9M
Q2 25
$359.4M
Q1 25
$648.1M
$362.6M
Q4 24
$711.3M
Q3 24
$764.9M
Q2 24
$734.3M
Q1 24
$779.7M
Debt / Equity
ACLX
ACLX
EU
EU
Q4 25
0.48×
Q3 25
0.44×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
EU
EU
Operating Cash FlowLast quarter
$-63.1M
$12.9M
Free Cash FlowOCF − Capex
$-63.9M
$7.2M
FCF MarginFCF / Revenue
-786.4%
57.8%
Capex IntensityCapex / Revenue
9.6%
46.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M
$-45.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
EU
EU
Q4 25
$12.9M
Q3 25
$-20.3M
Q2 25
$-9.9M
Q1 25
$-63.1M
$-7.7M
Q4 24
$-46.0M
Q3 24
$30.7M
Q2 24
$-36.2M
Q1 24
$-31.9M
Free Cash Flow
ACLX
ACLX
EU
EU
Q4 25
$7.2M
Q3 25
$-26.3M
Q2 25
$-14.1M
Q1 25
$-63.9M
$-11.7M
Q4 24
$-47.5M
Q3 24
$28.4M
Q2 24
$-39.5M
Q1 24
$-38.3M
FCF Margin
ACLX
ACLX
EU
EU
Q4 25
57.8%
Q3 25
-296.6%
Q2 25
-385.2%
Q1 25
-786.4%
-64.1%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
Q1 24
-97.7%
Capex Intensity
ACLX
ACLX
EU
EU
Q4 25
46.7%
Q3 25
68.0%
Q2 25
115.1%
Q1 25
9.6%
21.7%
Q4 24
9.8%
Q3 24
8.8%
Q2 24
11.7%
Q1 24
16.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons